Crossroads Systems 10-Q 9 Jun 14 2014 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Apr. 30, 2014	Jun. 09, 2014
Document Information [Line Items]	'	'
Entity Registrant Name	'CROSSROADS SYSTEMS INC	'
Entity Central Index Key	'0001093207	'
Current Fiscal Year End Date	'--10-31	'
Entity Filer Category	'Smaller Reporting Company	'
Trading Symbol	'CRDS	'
Entity Common Stock, Shares Outstanding	'	15,045,049
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Apr-14	'
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Apr. 30, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$10,723	$7,795
Accounts receivable, net of allowance for doubtful accounts of $98 and $94, respectively	2,013	2,301
Inventory	305	313
Prepaid expenses and other current assets	577	694
Total current assets	13,618	11,103
Property and equipment, net	707	1,031
Other assets	147	256
Total assets	14,472	12,390
Current liabilities:	'	'
Accounts payable	785	1,066
Accrued expenses	931	2,095
Deferred revenue	1,040	1,090
Current portion of long term debt, net of debt discount	3,501	1,605
Total current liabilities	6,257	5,856
Long term debt, net of debt discount	4,774	6,984
Long term derivative liability	0	772
Other long term liabilities	396	299
Commitments and contingencies (See Note 7)	'	'
Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized, 4,231,154 shares issued and outstanding, net at October 31, 2013 (transferred to stockholders equity as of April 30, 2014)	0	6,394
Stockholders' equity (deficit):	'	'
Common stock, $0.001 par value, 75,000,000 shares authorized, 15,045,049 and 11,949,937 shares issued and outstanding, respectively	15	12
Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized, 3,783,697 shares issued and outstanding, net as of April 30, 2014 (transferred from temporary equity)	4	0
Additional paid-in capital	225,091	208,702
Accumulated other comprehensive loss	-48	-51
Accumulated deficit	-222,017	-216,578
Total stockholders' equity (deficit)	3,045	-7,915
Total liabilities and stockholders' equity	$14,472	$12,390

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)	Apr. 30, 2014	Oct. 31, 2013
In Thousands, except Share data, unless otherwise specified
Allowance for Doubtful Accounts (in dollars)	$98	$94
Convertible Preferred Stock, Temporary Equity, Par Value (in dollars per share)	$0	$0.00
Convertible Preferred Stock, Temporary Equity, Shares Authorized	0	25,000,000
Convertible Preferred Stock, Temporary Equity, Shares Issued	0	4,231,154
Convertible Preferred Stock, Temporary Equity, Shares Outstanding	0	4,231,154
Common Stock, Par Value (in dollars per share)	$0.00	$0.00
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares Issued	15,045,049	11,949,937
Common Stock, Shares Outstanding	15,045,049	11,949,937
Convertible Preferred Stock, Par Value (in dollars per share)	$0.00	$0
Convertible Preferred Stock, Shares Authorized	25,000,000	0
Convertible Preferred Stock, Shares Issued	3,783,697	0
Convertible Preferred Stock, Shares Outstanding	3,783,697	0

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Revenue:	'	'	'	'
Product	$1,096	$1,046	$2,326	$2,964
IP license, royalty and other	1,199	1,691	4,094	3,324
Total revenue	2,295	2,737	6,420	6,288
Cost of revenue:	'	'	'	'
Product	204	186	440	380
IP license, royalty and other	256	622	639	1,376
Total cost of revenue	460	808	1,079	1,756
Gross profit	1,835	1,929	5,341	4,532
Operating expenses:	'	'	'	'
Sales and marketing	939	1,909	1,971	3,869
Research and development	1,517	2,990	3,048	5,847
General and administrative	1,180	905	2,518	1,781
Total operating expenses	3,636	5,804	7,537	11,497
Loss from operations	-1,801	-3,875	-2,196	-6,965
Gain on settlement	0	0	1,050	0
Loss before interest and derivative expense	-1,801	-3,875	-1,146	-6,965
Other expense:	'	'	'	'
Interest expense	-557	-80	-1,144	-134
Change in value of derivative liability	635	0	-2,765	0
Other expense	-18	5	-18	4
Net loss	-1,741	-3,950	-5,073	-7,095
Dividends attributable to preferred stock	-93	-864	-248	-864
Net loss available to common stockholders, basic and diluted	($1,834)	($4,814)	($5,321)	($7,959)
Net loss per share available to common stockholders, basic and diluted	($0.14)	($0.41)	($0.41)	($0.67)
Shares used in computing net loss per share:	'	'	'	'
Available to common stockholders, basic and diluted	13,577,795	11,836,140	12,963,235	11,827,430

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($5,073)	($7,095)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation	380	409
Non cash interest paid on conversion to preferred stock	0	55
Loss on change in value of derivative liability	2,765	0
Amortization of debt discount	667	0
Gain on disposal of property and equipment	-15	0
Stock-based compensation	1,008	557
Provision for doubtful accounts receivable	4	-5
Changes in assets and liabilities:	'	'
Accounts receivable	284	894
Inventory	8	78
Prepaid expenses and other assets	34	-168
Accounts payable	-277	-313
Accrued expenses	-1,150	-921
Deferred revenue	42	-108
Net cash used in operating activities	-1,323	-6,617
Cash flows from investing activities:	'	'
Purchase of property and equipment	-56	-273
Proceeds from sale of property and equipment	15	0
Net cash used in investing activities	-41	-273
Cash flows from financing activities:	'	'
Proceeds from issuance of common stock, net of expenses	5,123	27
Proceeds from issuance of preferred stock, net of expenses	0	7,333
Proceeds from issuance of bridge loan	0	550
Repayment of debt	-833	-1,963
Net cash provided by financing activities	4,290	5,947
Effect of foreign exchange rate on cash and cash equivalents	2	1
Net increase (decrease) in cash and cash equivalents	2,928	-942
Cash and cash equivalents, beginning of period	7,795	6,895
Cash and cash equivalents, end of period	10,723	5,953
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	492	74
Cash paid for income taxes	1	2
Supplemental disclosure of non cash financing activities:	'	'
Conversion of promissory note to preferred stock	0	605
Conversion of preferred stock to common stock	674	0
Common stock dividends issued to preferred shareholders	366	0
Conversion of derivative liability to equity	$3,537	$0

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	6 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'
Basis of Accounting [Text Block]	'
	1. ORGANIZATION AND BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements include the accounts of Crossroads Systems, Inc. and its wholly-owned subsidiaries (“Crossroads” or the “Company”).   Headquartered in Austin, Texas, Crossroads Systems, a Delaware corporation, is a global provider of data archive solutions.   Through the innovative use of new technologies, Crossroads delivers customer-driven solutions that enable proactive data security, advanced data archiving, optimized performance and significant cost-savings.
	The accompanying unaudited condensed consolidated financial statements of Crossroads Systems, Inc. have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with United States generally accepted accounting principles (“GAAP”). The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto together with management’s discussion and analysis of financial condition and results of operations contained in the Company’s 2013 Annual Report on Form 10-K filed on January 23, 2014 (“2013 Form 10-K”). In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments of a normal recurring nature considered necessary to fairly state the financial position of the Company at October 31, 2013 and April 30, 2014, the results of its operations for the three and six months ended April 30, 2014 and 2013, and its cash flows for the six months ended April 30, 2014 and 2013. The results of operations for the periods presented are not necessarily indicative of results that may be expected for the year ending October 31, 2014.
	Principles of Consolidation and presentation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of equity will be sufficient to fund the anticipated operations for fiscal 2014.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.
	The investment in KIP CR P1 LP (the Partnership (see Note 8)), is a partnership of which the Company is a limited partner and of which an affiliate of Fortress Investment Group, LLC is the general partner. The investment is accounted for using the equity method. The current investment balance is nominal at April 30, 2014.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.
	Computation of Net Loss Per Share
	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.
	The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was  12,811,794 and  9,587,096 for the three and six months ended April 30, 2014 and 2013, respectively. The dilutive common stock equivalents for the six months ended April 30, 2014 and 2013 include warrants to purchase 5,526,664  and 3,280,849 shares of common stock, 3,783,697 and 4,231,154 shares of preferred stock, which are excluded until converted to common shares (Note 8), and stock options to purchase 3,501,433 and 2,075,093 shares of common stock, respectively.
	Net loss available to common stockholders is calculated by deducting from net income preferred dividends paid and accrued of $  0.1 and $0.2 million for the three and six months ended April 30, 2014, respectively.
	Contracts to Modify or Customize Products
	The Company periodically enters into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, the Company first looks to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement.  The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and applies the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable.  Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.
	Recently Issued Accounting Pronouncements
	In July 2013, the FASB issued new accounting guidance on the presentation of unrecognized tax benefits. This new guidance requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists, with limited exceptions. The prospective adoption of this new accounting guidance in the first quarter of 2014 did not have a material impact on our consolidated financial position, results of operations or cash flows.
	In March 2013, the FASB issued guidance that requires a parent company to release any related cumulative translation adjustment into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. The adoption of this new accounting guidance in the first quarter of 2014 did not have a material impact on our consolidated financial position, results of operations or cash flows.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Apr. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	2. FAIR VALUE MEASUREMENTS
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is applied as follows:
	Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.
	Level 2 –  Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
	Level 3 – Valuations based on unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
	As of April 30, 2014, the fair value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximates book value due to the short maturity of these instruments. Based upon borrowing rates currently available to the Company for loans with similar terms, the carrying value of its debt obligations approximates fair value. As of April 30, 2014 and October 31, 2013, the Company held no investments.
	In accordance with ASC 815-40-25 and ASC 815-10-15 Derivatives and Hedging and ASC 480-10-25 Liabilities-Distinguishing Liabilities from Equity as approved by shareholders, the Company’s shares of 5.0% Series F Convertible Preferred Stock was accounted for net outside of stockholders’ equity at $6.4 million and the warrants issued in connection with the convertible preferred stock accounted for as liabilities at their fair value of $0.8 million as of October 31, 2013. The value of the derivative warrant liability was re-measured at each reporting period with changes in fair value recorded as change in value of derivative liability. To derive an estimate of the fair value of these warrants, the Company utilized a dynamic Black Scholes Merton formula that computes the impact of share dilution upon the exercise of the warrant shares. This process relies upon inputs such as shares outstanding, estimated stock prices, strike price and volatility assumptions to dynamically adjust the payoff of the warrants in the presence of the dilution effect. In the event the convertible preferred shares are redeemed, any redemption price in excess of the carrying amount of the convertible preferred stock would be treated as a dividend. The change in liabilities measured using significant unobservable inputs for the six months ended April 30, 2014 were as follows (in thousands) (see Note 8 explaining the revaluation of Series-F Preferred Stock and Warrants):
	Level 3 Roll-forward
		Derivative Liability
	Balance October 31, 2013	$	772
	Derivative liability converted to equity upon exercise		-215
	Change in fair value of derivative liability		2,765
	Derivative liability reclassified to equity upon ratchet expiration		-3,322
	Balance April 30, 2014 (Unaudited)	$	-

INVENTORY

INVENTORY	6 Months Ended
	Apr. 30, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	3. INVENTORY
	Inventory, net consists of the following (in thousands):
		April 30,		October 31,
		2014		2013
		(Unaudited)
	Raw materials	$	199	$	204
	Finished goods		106		109
		$	305	$	313

PROPERTY_AND_EQUIPMENT

PROPERTY AND EQUIPMENT	6 Months Ended
	Apr. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	4. PROPERTY AND EQUIPMENT
	Property and equipment, net consist of the following (in thousands, except number of years):
				April 30,		October 31,
				2014		2013
		Life (years)		(Unaudited)
	Equipment		3-Jan	$	17,659	$	18,390
	Furniture and fixtures		5		796		789
	Leasehold improvements		5		576		576
					19,031		19,755
	Less: Accumulated depreciation				-18,324		-18,724
				$	707	$	1,031
	Depreciation expense was approximately $380,000 and $409,000 for six months ended April 30, 2014 and 2013, respectively.

ACCRUED_EXPENSES_AND_DEFERRED_

ACCRUED EXPENSES AND DEFERRED REVENUE	6 Months Ended
	Apr. 30, 2014
Payables and Accruals [Abstract]	'
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	'
	5. ACCRUED EXPENSES AND DEFERRED REVENUE
	Accrued expenses consist of the following (in thousands):
		April 30,		October 31,
		2014		2013
		(Unaudited)
	Payroll related	$	550	$	1,470
	Professional services		226		359
	Warranty reserve		48		41
	Other		107		225
		$	931	$	2,095
	Included in payroll related accrued expenses as of October 31, 2013 was $202,000 related to bonus compensation, $135,000 of which was settled in January 2014 with 66,081 shares of common stock.   Also included in payroll related accrued expenses as of October 31, 2013 was $326,000 of unpaid severance, relating to the reduction in force which occurred October 24, 2013, and $142,000 of unpaid severance, relating to the termination of the Company’s previous CEO on May 8, 2013.
	Warranty reserve activity, included in accrued expenses, during the year ended October 31, 2013 and six months ended April 30, 2014 was as follows (in thousands):
		Balance at		Charged to				Balance at
		Beginning		Costs and		Reserve		End of
		of Period		Expenses		Usage		Period
	Year ended October 31, 2013
	Warranty reserve	$	11	$	58	$	-28	$	41
	Six months ended April 30, 2014
	Warranty reserve (Unaudited)	$	41	$	17	$	-10	$	48
	Deferred revenue, current portion, consists of the following (in thousands):
		April 30,		October 31,
		2014		2013
		(Unaudited)
	Product	$	40	$	47
	Services		1,000		1,043
		$	1,040	$	1,090

LINE_OF_CREDIT_AND_LONG_TERM_L

LINE OF CREDIT AND LONG TERM LIABILITIES	6 Months Ended
	Apr. 30, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	6. LINE OF CREDIT AND LONG TERM LIABILITIES
	Effective July 22, 2013, the Company entered into a credit agreement (the Credit Agreement) with Fortress Credit Co. LLC, an affiliate of Fortress Investment Group LLC (collectively referred to as Fortress) that provided for aggregate term loan commitments of up to $10.0 million. The Credit Agreement consisted of a Term Loan A in the principal amount of $5.0 million, maturing on July 22, 2016 and bearing no interest for the first 12 months, and a Term Loan B in the principal amount of $5.0 million, maturing on February 1, 2016 and bearing no interest for the first six months. The Company drew down the full $10.0 on Term Loan A and Term Loan B (collectively referred to as Fortress Term Loans) on July 24, 2013. The Fortress Term Loans accrue interest at 10% annually after the interest free period and interest is due monthly in arrears. The Company will begin making principal payments on Term Loan A in July 2014. The proceeds from the Fortress Term Loans were used to pay off the Company’s outstanding revolving credit and term loan with Silicon Valley bank.
	Debt issuance costs associated with the Fortress Term Loans totaling $1.7 million were recorded as a deferred charge and are being amortized over the term of the debt using the effective interest rate method with an effective interest rate of 13.37% as opposed to the statutory rate of 10%. The effective interest rate is higher due to the use of the effective interest method to calculate the monthly expense, which includes debt discount and loan origination fee amortization.
	In connection with the Credit Agreement, the Company issued warrants to Fortress to purchase 1,454,545 shares of the Company’s common stock at an exercise price of $2.0625 per share (the Fortress Warrants). See Note 8 for discussion of the Fortress Warrants.
	In addition, the Company also transferred substantially all of its patents, other than its ’972 patent family, to a limited partnership KIP CR P1 LP of which the Company is a limited partner and of which an affiliate of Fortress is the general partner. The partnership now controls 117 pending or granted non-’972 patents. There was no licensing activity during fiscal year 2013 associated with these patents. The general partner cannot be removed without the consent of Fortress. The Company accounts for the investment in the partnership on a consolidated basis using the equity method of accounting.
	In conjunction with the Credit Agreement the Company agreed to certain financial covenants. The Company is required to maintain a minimum of $1.5 million of unrestricted cash at each month end and the Company is restricted from making certain cash distributions to equity security holders or from incurring additional indebtedness without prior written consent from Fortress. The Company has also agreed to certain reporting covenants and must supply monthly financial statements to Fortress within 30 days of the end of each month.
	These warrants also previously contained what is commonly known as a “full-ratchet” anti-dilution provision, which provided that if the Company issued or were deemed to have issued additional shares of common stock without consideration or for a consideration per share less than the applicable exercise price of the Fortress Warrants, which is initially $2.0625 per share, then the exercise price of the warrants will be reduced on a “full ratchet” basis, concurrently with the new issue, to the consideration per share the Company received for the new issue or deemed issue of the additional shares of common stock.. In January 2014, the Company and the warrantholder agreed to amend the warrant to remove this full-ratchet anti-dilution provision.
	The principal balance due to Fortress is as follows (in thousands):
		April 30,
		2014
		(Unaudited)
	Principal balance Fortress Term Loans	$	9,167
	Principal balance other		35
	Unaccreted debt discount		-927
	Net carrying value due Fortress		8,275
	Less current portion		-3,501
	Long term portion	$	4,774

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Apr. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	7. COMMITMENTS AND CONTINGENCIES
	Leases
	The Company leases office space and equipment under long-term operating lease agreements that expire on various dates through March 31, 2020. Rental expense under these agreements was approximately $191,000 and $205,000 for the six months ended April 30, 2014 and 2013, respectively. Crossroads leases its headquarters, approximately 37,800 square feet of general office, laboratory, data center and administrative space in Austin, Texas. The original lease was effective October 31, 2005 and extended in accordance with an extension agreement through February 28, 2015. On May 2, 2014, the lease was amended, extending the lease through March 31, 2020, and reducing the space leased to 16,200 square feet. The extended term of the lease represents a lease commitment of approximately $264,000 per year through the lease term.
	Legal Proceedings
	Intellectual Property Litigation
	The Company filed a lawsuit on September 11, 2013 against Dot Hill Systems Corp. ("Dot Hill") styled Crossroads Systems, Inc. v. Dot Hill Systems Corp., Civil Action No. 1:13-CV-800-SS alleging patent infringement and breach of the Amended Settlement and License Agreement dated June 27, 2006 between Crossroads and Dot Hill. Dot Hill has filed a motion to dismiss and Crossroads has filed its response; the Court denied Dot Hill’s motion.  Dot Hill recently filed a partial motion for summary judgment and Crossroads is preparing its response.   The Markman hearing is scheduled for October 6-7, 2014.
	The Company filed a lawsuit on October 7, 2013 against Oracle Corporation alleging infringement by Oracle Corporation of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc., v. Oracle Corporation; Civil Action No. 1:13-CV-895-SS (W.D. Tex., Austin Division)). Oracle has answered the complaint and the action is pending.  The Markman hearing is scheduled for October 6-7, 2014.
	The Company filed a lawsuit on November 26, 2013 against Tandberg Data Corporation alleging infringement by Tandberg Data Corporation of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Tandberg Data Corporation; Civil Action No. 1:13-cv-01026-SS (W.D. Tex., Austin Division)). This case was settled during the fiscal third quarter, subsequent to April 30, 2014, and dismissed.
	The Company filed a lawsuit on November 26, 2013 against Huawei Technologies Co. Ltd., Huawei Enterprise USA, Inc. & Huawei Technologies USA, Inc. alleging infringement of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Huawei Technologies Co., Ltd. et al; Civil Action No. 1:13-cv-01025-SS (W.D. Tex., Austin Division)). Huawei has answered the complaint and the action is pending.  The Markman hearing is scheduled for October 6-7, 2014.
	The Company filed a lawsuit on November 26, 2013 against Dell Inc. alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Dell Inc.; Civil Action No. 1:13-cv-01023-SS (W.D. Tex., Austin Division)). Dell has answered the complaint and the action is pending.  The Markman hearing is scheduled for October 6-7, 2014.
	The Company filed a lawsuit on February 18, 2014 against Cisco Systems, Inc. alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Dell Inc.; Civil Action No. 1:14-cv-00148-SS (W.D. Tex., Austin Division)).  Cisco has answered the complaint and the action is pending.  The Markman hearing is scheduled for October 6-7, 2014.
	The Company filed a lawsuit on February 18, 2014 against NetApp, Inc. alleging infringement of U.S. Patent Nos. 6,425,035, 7,934,041, 7,987,311 and 7,051,147 (the case is styled Crossroads Systems, Inc. v. Dell Inc.; Civil Action No. 1:14-cv-00149-SS (W.D. Tex., Austin Division)).   NetApp has answered and filed a motion to dismiss the action is pending.  The Markman hearing is scheduled for October 6-7, 2014.
	The Company filed a lawsuit on February 18, 2014 against Quantum Corporation alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Dell Inc.; Civil Action No. 1:14-cv-00150-SS (W.D. Tex., Austin Division)).  Quantum has answered the complaint and the action is pending.  The Markman hearing is scheduled for October 6-7, 2014.
	On April 15, 2014, NetApp, Inc. filed an action for declaratory judgment of non-infringement of U.S. Patent Nos. 7,987,311 and 7,051,147 (the case is styled NetApp, Inc. v. Crossroads Systems, Inc.; Civil Action No. 4:14-CV-01727-JSW (N.D. Cal., Oakland Division).  Crossroads has filed a motion to dismiss this action.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Apr. 30, 2014
Stockholders Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	8. STOCKHOLDERS’ EQUITY
	2010 Private Placement
	On October 23, 2010 the Company sold 3,125,000 shares of its common stock at $3.20 per share for gross proceeds to the Company of $ 10.0 million.  In conjunction with this private placement, the Company also issued warrants to purchase an additional 1,074,212 shares of common stock with an exercise price of $3.20 per share.   Fees in the amount of $0.8 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.3 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 63%, risk free interest rate of 1.47%, and expected term of 5 years.  The warrants were exercisable immediately upon issue, and expire October 22, 2015. As of April 30, 2014, there were 949,034 warrants outstanding.
	Iron Mountain Private Placement
	On July 31, 2012, the Company issued and sold to Iron Mountain Incorporated (“IRM”) 582,524 shares of its common stock at $5.15 per share, for an aggregate purchase price of $3 million. The Company also entered in a registration rights agreement with IRM, pursuant to which the Company agreed to prepare and file a registration statement with the Securities and Exchange Commission (“SEC”) at IRM’s request, no later than sixty days following such request, and to keep it continuously effective until the shares covered by the registration statement have been sold or become eligible for sale pursuant to SEC Rule 144 without restriction on the volume of securities that may be sold in any single transaction, assuming for this purpose that the security holders are not affiliates of the Company.  The shares were registered with the SEC in fiscal year 2013.
	2013 Private Placement
	On March 22, 2013, the Company entered into a securities purchase agreement with certain accredited investors for the issuance and sale in a private placement of 4,231,154 units at a purchase price of $2.0625 per unit, valued at $8.6 million, for net proceeds of approximately $7.9 million after related expenses. Each unit consists of one share of cumulative 5.0% Series F convertible preferred stock, par value $0.001 per share and a warrant to purchase one-half of a share of common stock equal per share of convertible preferred stock purchased, at an exercise price of $2.00 per whole share, subject to certain adjustments, resulting in the issuance of warrants to purchase an additional 2,282,754 shares of common stock with an exercise price of $2.00 per share. The convertible preferred stock ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. The warrants were initially valued using the Black-Scholes pricing model at approximately $2,284,000.  The relative fair value of these warrants totaling $1,543,000 was initially allocated to additional paid in capital.  The Black-Scholes inputs used were:  expected dividend rate of 0 %, expected volatility of 63%, risk free interest rate of 0.82 %, and expected term of 5 years.  This valuation resulted in a beneficial conversion feature on the convertible preferred stock of approximately $1,090,000. This amount was recorded, upon issuance, as a deemed dividend.   Fees in the amount of $0.7 million relating to the stock placement were netted against proceeds.   The warrants were exercisable immediately upon issue, and expire March 22, 2018.   Stock dividends valued at $ 106,000 were issued in fiscal year 2013, by issuing 57,097 shares of common stock.  During the three months ended January 31, 2014, the Company issued 150,703 dividend common shares valued at approximately $366,000. The next dividend is due June 30, 2014.
	The warrants related to the Series F Preferred Shares were revalued at October 31, 2013 using the Black-Scholes pricing model at approximately $772,000.  The dynamic Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 65%, risk free interest rate of 1.10%, and expected term of 4.4 years. Upon the expiration of the ratchet, the warrant liability was $0.
	The convertible preferred stock has the rights, qualifications, limitations and restrictions set forth in the Certificate of Designation (the “Certificate of Designation”) filed with the Secretary of State of the State of Delaware on March 28, 2013. The Certificate of Designation authorizes issuance of up to 4,500,000 shares of convertible preferred stock, with 3,750,000 shares designated as “Sub-Series F-1” and 750,000 shares designated as “Sub-Series F-2.” The right of holders of convertible preferred stock to convert the convertible preferred stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2. Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the Original Issue Date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company. If less than 90%, but at least 20%, of such shares of Sub-Series F-1 are outstanding, such holders, voting as a single class, will be entitled to elect one director of the Company. As of the date hereof, less than 90% of the aggregate number of shares of Sub-Series F-1 are outstanding, as the remainder have been voluntarily converted into common stock at the option of the holders. Therefore, the holders of the Sub-Series F-1 shares are entitled to elect one director to the board of directors. The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1. The holders of shares of the convertible preferred stock are entitled to a liquidation preference equal to the original issuance price plus any unpaid dividends.
	The Certificate of Designation contains customary anti-dilution protection for proportional adjustments (e.g. stock splits). The Series F convertible preferred stock previously included an anti-dilution provision that would adjust the conversion price of the Series F convertible preferred stock to the issue price of any equity securities the Company issued at a price less than $2.0625 per share, subject to certain exceptions. This type of provision is commonly referred to as a “full-ratchet” anti-dilution provision. This “full-ratchet” provision is no longer in effect as it was removed from the Certificate of Designation on March 14, 2014 by the requisite approval of the holders of shares of the Company’s common stock and Series F convertible preferred stock.
	The full ratchet anti-dilution provisions in the Company’s convertible preferred stock and warrants issued in its March 2013 private placement (discussed above) were not in effect until those provisions were approved by a vote of the Company’s stockholders at its 2013 annual meeting held on June 21, 2013. Upon approval of these provisions the warrants were reclassified as a derivative liability and recorded at fair value. Also upon approval of the full ratchet anti-dilution provision the Series F convertible preferred stock were potentially convertible into more shares of common stock than currently authorized, therefore those shares were classified in temporary equity. Upon the expiration of the full ratchet anti-dilution provisions in March 2014, the Company reclassified the preferred stock and warrants to permanent stockholders' equity following the stockholders vote described in the preceding paragraph.
	In accordance with ASC 815-40-25 and ASC 815-10-15 Derivatives and Hedging and ASC 480-10-25 Liabilities-Distinguishing Liabilities from Equity as approved by shareholders, the convertible preferred shares were accounted for net outside of stockholders’ equity at $6.4 million with the warrants accounted for as liabilities at their fair value of $0.8 million as of October 31, 2013. The ratchet included with the warrants expired during the second quarter of 2014 and as a result the value of the derivative warrant liability was $0 as of April 30, 2014.
	In the event the convertible preferred shares are redeemed, any redemption price in excess of the carrying amount of the convertible preferred stock would be treated as a dividend. During the six months ended April 30, 2014, there were 447,457 shares of Series F Preferred shares converted to common shares.
	The Company filed a registration statement to register these securities on Form S-1 on May 10, 2013 with the Securities and Exchange Commission (“SEC”).
	Dividends on the Series F convertible preferred stock will accrue at an annual rate of 5.0% of the original issue price and will be payable on a semi-annual basis. The convertible preferred ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. Pursuant to a registration rights agreement entered into with the purchasers of the Series F convertible preferred stock, in the event that a registration statement for the resale of the common stock underlying the convertible preferred stock and March 2013 warrants was not declared effective prior to July 26, 2013 (120 days from the closing of the March 2013 private placement), then the rate at which dividends accrued on the convertible preferred stock would be increased to an annual rate of 12.0% from that date until such time as a registration statement is declared effective, at which time the dividend rate reverts to an annual rate of 5.0%. The registration statement was not declared effective by July 26, 2013, and as a result the dividend rate on the convertible preferred stock increased to an annual rate of 12.0%, until September 19, 2013 when it was declared effective. The Company may elect to satisfy the obligation to pay semi-annual dividends in cash, by distribution of common stock or a combination thereof, in the Company’s discretion.
	On February 28, 2013, in connection with the 2013 Private Placement, the Company issued convertible promissory notes to two investors, in the aggregate principal amount of $550,000. Pursuant to the terms of the notes, both note holders had the right to convert the outstanding amounts under their notes into Series F convertible preferred stock shares at a discount of 15% to the issue price of the Series F convertible preferred stock. This resulted in a beneficial conversion feature of $107,000. Each note holder exercised this right and received 188,235 Series F convertible preferred stock shares, in the case of the note holder converting $330,000 of promissory notes and interest, and 156,863 Series F convertible preferred stock shares, in the case of note holder converting $275,000 of promissory notes and interest.
	2013 Fortress Credit Agreement
	As discussed in Note 6, on July 22, 2013 the Company issued warrants to purchase 1,454,545 shares of its common stock to Fortress at $2.0625 per share. To derive an estimate of the fair value of these warrants, the Company utilized a dynamic Black Scholes Merton formula that computes the impact of share dilution upon the exercise of the warrant shares. This process relies upon inputs such as shares outstanding, estimated stock prices, strike price and volatility assumptions to dynamically adjust the payoff of the warrants in the presence of the dilution effect.   The Fortress Warrant was recorded at a fair value of $1,374,000 or $ 1.0625 per underlying warrant share.
	The Fortress Warrant is exercisable on or after October 22, 2013 and will expire on the seventh anniversary of the effective date of the Fortress Transactions. If the Fortress Warrant is exercisable and there is no effective Registration Statement registering, or no current prospectus available for, the resale of the shares of common stock issuable upon exercise of the Fortress Warrant, then the Fortress Warrant may also be exercised at such time by means of a “cashless exercise,” determined according to the terms of the Fortress Warrant.
	The Fortress Warrants included what is commonly referred to as “full-ratchet” anti-dilution protection, which provision would only have gone into effect if approved by the Company’s stockholders at its 2014 annual meeting of stockholders. Subject to stockholder approval, if, prior to the earlier to occur of (A) twelve months following the warrant, issuance date of July 22, 2013 and (B) the date on which the Company indicates a positive earnings per share in its public disclosure, the Company issued or was deemed to have issued additional shares of Common Stock without consideration or for a consideration per share less than the applicable exercise price, which is initially $2.0625 per share, then the exercise price of the Fortress Warrant would have been reduced, concurrently with such issue, to the consideration per share received by the Company for such issue or deemed issue of the additional shares of common stock.
	On January 23, 2014, Crossroads Systems, Inc. entered into an Amendment to the Fortress Warrants with CF DB EZ LLC, which is an affiliate of Fortress. The sole purpose of this amendment was to remove the “full-ratchet” anti-dilution provision of the warrant that Crossroads issued to Fortress.
	2014 Private Placement
	On March 31, 2014 the Company sold 1,986,622 units at $2.2565 per unit for gross proceeds to the Company of $ 4.5 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 993,311 shares of common stock have a weighted average exercise price of $2.45 per share.   Fees in the amount of $0.2 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.1 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 74%, risk free interest rate of 1.64%, and expected term of 2.5 years.  The warrants were exercisable upon the six-month anniversary of issue, and expire March 31, 2019. As of April 30, 2014, there were 993,311 warrants outstanding.
	As a result of credit, common stock and preferred stock transactions, the Company has the following common stock warrants outstanding at April 30, 2014:
	Warrants Outstanding
	Warrant Transaction	Warrants		Weighted
		Outstanding		Average Exercise
				Price
	2010 Private Placement		949,034	$	3.2
	2013 Private Placement		2,129,774	$	2
	2013 Fortress Credit Agreement		1,454,545	$	2.06
	2014 Private Placement		993,311	$	2.45
	Total Warrants		5,526,664
	A rollforward of activity in stockholders equity is presented in the following table as of April 30, 2014 (in thousands, unaudited):
						Additional				Accumulated		Total
		Preferred Stock		Common Stock		Paid-In		Accumulated		Other Comprehensive		Stockholders'
		Amount		Amount		Capital		Deficit		Loss		Equity (Deficit)
	Balance at October 31, 2013	$	-	$	12	$	208,702	$	-216,578	$	-51	$	-7,915
	Transfer preferred stock from temporary equity		4		-		6,390		-		-		6,394
	Stock based compensation, options and warants		-		1		1,977		-		-		1,978
	Expiration of derivative liability		-		-		3,322		-		-		3,322
	Common stock dividends issued to preferred shareholders		-		-		366		-366		-		-
	Sale of common stock		-		2		4,334		-		-		4,336
	Foreign currency translation adjustment		-		-		-		-		3		3
	Net loss		-		-		-		-5,073		-		-5,073
	Balance at April 30, 2014	$	4	$	15	$	225,091	$	-222,017	$	-48	$	3,045

STOCK_OPTIONS_AND_STOCK_BASED_

STOCK OPTIONS AND STOCK BASED COMPENSATION	6 Months Ended
	Apr. 30, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
		9	STOCK OPTIONS AND STOCK BASED COMPENSATION
	The Company has a stock-based compensation plan available to grant incentive stock options, non-qualified stock options and restricted stock to employees and non-employee members of the board of directors and advisors.
	The Company’s 2010 Stock Incentive Plan (the “2010 Plan”) succeeded the 1999 Stock Option/Stock Issuance Plan (the “1999 Plan.  As of April 30, 2014, options to purchase 663,442 shares of common stock were outstanding under the 1999 Plan, and no further grants can be made under the 1999 Plan.
	The 2010 Plan was approved by the board of directors on May 26, 2010 and became effective on August 13, 2010, upon approval by shareholders.  A maximum of 3,500,000 shares of Crossroads common stock may be awarded, plus the automatic increase as detailed below. The total number of shares that will be reserved, and that may be issued, under the 2010 Plan will automatically increase on the first trading day of each calendar year, by a number of shares equal to four percent (4%) of the total outstanding shares on the last day of the prior calendar year, subject to a maximum annual increase of 250,000.   As of April 30, 2014, options to purchase 3,670,622 shares of common stock were granted from the 2010 Plan, of which 2,837,991 were outstanding. During the six months ended April 30, 2014 and 2013, common stock share grants of 66,081 and 146,555, respectively, were granted from the 2010 Plan.
	As of April 30, 2014, options to purchase an aggregate of 3,501,433 shares of common stock were outstanding under the 1999 Plan and the 2010 Plan, of which 1,917,918 were vested. Under the 2010 Plan, 143,634 shares of common stock were available for future grants as of April 30, 2014.  The shares of common stock reserved for future grant are reduced by 221,780 options previously exercised under the 2010 Plan, and 296,595 shares of stock granted under the 2010 Plan.  The Compensation Committee of the Board of Directors determines the exercise price, term and other conditions applicable to each stock option granted under the 2010 Plan. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of the Company’s stock on that date (at market close). The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. During 2014, the majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter. Stock option exercises are fulfilled with new shares of common stock.
	The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:
			Six months ended April 30,
			2014			2013
			(Unaudited)			(Unaudited)
	Cost of revenue		$	21		$	14
	Sales and marketing			232			144
	Research and development			362			167
	General and administrative			393			232
	Total stock-based compensation		$	1,008		$	557
	During the year ended October 31, 2013, share based compensation expense of approximately $147,000 was accrued for 67% of the total estimated management bonus for the fiscal year ended October 31, 2013. Accordingly, 66,081 shares of common stock were granted in January 2014 to satisfy this liability.
	The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. Expected volatility is based on historical volatility of the Company’s stock. The expected term represents an estimate of the time options are expected to remain outstanding based upon historical analysis. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve in effect at the time of grant. The variables used in the Black-Scholes calculation are listed below for the respective periods:
			Six months ended April 30,
			2014				2013
	Expected dividend yield			0	%			0	%
	Expected volatility			73 - 79	%			71 - 74	%
	Risk-free interest rate			1.4 - 1.7	%			0.7 - 0.9	%
	Expected term (years)			5-Apr				6.5
	The following table summarizes information about stock option activity for the three months ended April 30, 2014 (unaudited):
			Number of			Weighted			Weighted Average		Aggregate
			Shares			Average			Remaining		Intrinsic
						Exercise Price			Contractual Term		Value ($M)
									(years)
	Outstanding at October 31, 2013			3,320,910		$	2.71			6.43	$	-
	Granted			639,088		$	1.81
	Forfeited			-216,357		$	4.88
	Exercised			-242,208		$	1.56
	Outstanding and expected to vest at April 30, 2014			3,501,433		$	2.49			7.23	$	1.1
	Exercisable at April 30, 2014			1,917,918		$	2.91			5.62	$	0.6
	The weighted average fair value per option granted during the six months ended April 30, 2014 and 2013 was $1.16 and $1.65 respectively. The total intrinsic value of options (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) exercised during the six months ended April 30, 2014 and 2013 was $217,000 and $15,200 respectively. During the six months ended April 30, 2014 and 2013, the amount of cash received from the exercise of stock options was $377,000 and $27,000, respectively.
	The Company granted 10,000 options to non-employees during the six months ended April 30, 2014 with a fair value of approximately $14,000, and granted 60,000 options during the six months ended April 30, 2013, with a fair value of approximately $95,000.
	At April 30, 2014, there was approximately $0.9 million of total unrecognized compensation cost related to non-vested stock option awards which is expected to be recognized over a weighted-average period of 0.9 year. There were 534,969 and 206,595 options that became vested during the six months ended April 30, 2014 and 2013, respectively, with the total fair value of these awards of approximately $684,000 and $424,000 respectively.
	The following table shows information about outstanding stock options at April 30, 2014:
									Options Outstanding						Options Exercisable
											Weighted
											Average		Weighted				Weighted
	Range of								Shares		Remaining		Average				Average
	Exercise Prices								Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
	$	-		-		$	1.03			184,606		7.7	$	0.89		184,606	$	0.89
	$	1.21		-		$	1.21			395,000		9.5	$	1.21		98,750	$	1.21
	$	1.24		-		$	1.54			521,506		9.51	$	1.5		184,006	$	1.43
	$	1.54		-		$	2.04			342,616		6.24	$	1.63		298,275	$	1.62
	$	2.04		-		$	2.1			864,368		9.12	$	2.1		199,137	$	2.1
	$	2.1		-		$	3.52			423,429		6.03	$	2.92		266,704	$	3.16
	$	3.52		-		$	4.75			524,172		3.23	$	4.58		463,327	$	4.58
	$	4.75		-		$	7.2			245,736		3.77	$	5.2		223,113	$	5.23
	$	-		-		$	7.2			3,501,433		7.23	$	2.49		1,917,918	$	2.91

EMPLOYEE_BENEFITS

EMPLOYEE BENEFITS	6 Months Ended
	Apr. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	10	EMPLOYEE BENEFITS
	In 1996, the Company established the Crossroads Systems, Inc. 401(k) Savings Plan (the “Savings Plan”), which is a qualified plan under section 401(k) of the Internal Revenue Code.   All employees who have attained 18 years of age are eligible to enroll in the Savings Plan.   The Company may make matching contributions to those employees participating in the Savings Plan based upon Company productivity and profitability. Company contributions vest over a period of six years.   In October 2000, the Company adopted a new 401(k) Savings Plan that meets all of the criteria set forth above in the Savings Plan.   The Company made matching contributions $91,000 and $149,000 during the six months ended April 30, 2014 and 2013, respectively.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Apr. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	11	RELATED PARTY TRANSACTIONS
	Iron Mountain
	On December 19, 2013, the Company and IRM mutually agreed to end their contract involving the development of a co-branded product.   The Company received $1.6 million in connection with the terminated contract in the first quarter of fiscal year 2014.   The Company bifurcated the payment between amounts received for work performed on the development of the product of $550,000, and a gain from settlement of $1,050,000. The Company recorded the amounts attributable to development as services revenue, and the gain on settlement was reflected as a reduction in operating expenses. IRM also agreed that it would not transfer the shares without the Company's prior written consent until the two-year anniversary date of the settlement, and that it would vote the shares consistent with the recommendation of Crossroads’ Board of Directors.
	2014 Private Placement
	The lead investor in the 2014 Private Placement (see Note 8) was Lone Star Value Investors, LP (“LSVI”). LSVI is controlled by Crossroads’ Chairman of the Board of Directors, Jeffrey E. Eberwein. LSVI acquired 1,288,352 shares in the placement, which included warrants to purchase 644,176 shares of common stock at an exercise price of $2.46 per share, for approximately $2.9 million.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Apr. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	12	SUBSEQUENT EVENTS
	On May 23, 2014, the Company’s board of directors adopted a Tax Benefit Preservation Plan to help deter acquisitions of the Company’s common stock that could result in an ownership change under Section 382 of the Internal Revenue Code, and thus help preserve the value of certain deferred tax benefits, including net operating loss, or NOL, carryforwards. The Tax Benefit Preservation Plan is designed to deter acquisitions of the Company’s common stock that would result in a stockholder owning 4.99% or more of the Company’s common stock (as calculated under Section 382 of the Internal Revenue Code), or any existing holder of 4.99% or more of the Company’s common stock acquiring additional shares, by substantially diluting the ownership interest of any such stockholder unless the stockholder obtains an exemption from the Company’s board of directors. The adoption of the Tax Benefit Preservation Plan is intended to reduce the likelihood that changes in our investor base have the unintended effect of limiting our use of NOL carryforwards to our tax benefit in the future.

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Policies)	6 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation and presentation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of equity will be sufficient to fund the anticipated operations for fiscal 2014.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.
	The investment in KIP CR P1 LP (the Partnership (see Note 8)), is a partnership of which the Company is a limited partner and of which an affiliate of Fortress Investment Group, LLC is the general partner. The investment is accounted for using the equity method. The current investment balance is nominal at April 30, 2014.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.
Earnings Per Share, Policy [Policy Text Block]	'
	Computation of Net Loss Per Share
	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.
	The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was  12,811,794 and  9,587,096 for the three and six months ended April 30, 2014 and 2013, respectively. The dilutive common stock equivalents for the six months ended April 30, 2014 and 2013 include warrants to purchase 5,526,664  and 3,280,849 shares of common stock, 3,783,697 and 4,231,154 shares of preferred stock, which are excluded until converted to common shares (Note 8), and stock options to purchase 3,501,433 and 2,075,093 shares of common stock, respectively.
	Net loss available to common stockholders is calculated by deducting from net income preferred dividends paid and accrued of $  0.1 and $0.2 million for the three and six months ended April 30, 2014, respectively.
Contracts To Modify Or Customize Products [Policy Text Block]	'
	Contracts to Modify or Customize Products
	The Company periodically enters into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, the Company first looks to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement.  The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and applies the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable.  Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Issued Accounting Pronouncements
	In July 2013, the FASB issued new accounting guidance on the presentation of unrecognized tax benefits. This new guidance requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists, with limited exceptions. The prospective adoption of this new accounting guidance in the first quarter of 2014 did not have a material impact on our consolidated financial position, results of operations or cash flows.
	In March 2013, the FASB issued guidance that requires a parent company to release any related cumulative translation adjustment into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. The adoption of this new accounting guidance in the first quarter of 2014 did not have a material impact on our consolidated financial position, results of operations or cash flows.

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Apr. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	The change in liabilities measured using significant unobservable inputs for the six months ended April 30, 2014 were as follows (in thousands) (see Note 8 explaining the revaluation of Series-F Preferred Stock and Warrants):
	Level 3 Roll-forward
		Derivative Liability
	Balance October 31, 2013	$	772
	Derivative liability converted to equity upon exercise		-215
	Change in fair value of derivative liability		2,765
	Derivative liability reclassified to equity upon ratchet expiration		-3,322
	Balance April 30, 2014 (Unaudited)	$	-

INVENTORY_Tables

INVENTORY (Tables)	6 Months Ended
	Apr. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
	Inventory, net consists of the following (in thousands):
		April 30,		October 31,
		2014		2013
		(Unaudited)
	Raw materials	$	199	$	204
	Finished goods		106		109
		$	305	$	313

PROPERTY_AND_EQUIPMENT_Tables

PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Apr. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	Property and equipment, net consist of the following (in thousands, except number of years):
				April 30,		October 31,
				2014		2013
		Life (years)		(Unaudited)
	Equipment		3-Jan	$	17,659	$	18,390
	Furniture and fixtures		5		796		789
	Leasehold improvements		5		576		576
					19,031		19,755
	Less: Accumulated depreciation				-18,324		-18,724
				$	707	$	1,031

ACCRUED_EXPENSES_AND_DEFERRED_1

ACCRUED EXPENSES AND DEFERRED REVENUE (Tables)	6 Months Ended
	Apr. 30, 2014
Payables and Accruals [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
	Accrued expenses consist of the following (in thousands):
		April 30,		October 31,
		2014		2013
		(Unaudited)
	Payroll related	$	550	$	1,470
	Professional services		226		359
	Warranty reserve		48		41
	Other		107		225
		$	931	$	2,095
Schedule of Product Warranty Liability [Table Text Block]	'
	Warranty reserve activity, included in accrued expenses, during the year ended October 31, 2013 and six months ended April 30, 2014 was as follows (in thousands):
		Balance at		Charged to				Balance at
		Beginning		Costs and		Reserve		End of
		of Period		Expenses		Usage		Period
	Year ended October 31, 2013
	Warranty reserve	$	11	$	58	$	-28	$	41
	Six months ended April 30, 2014
	Warranty reserve (Unaudited)	$	41	$	17	$	-10	$	48
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	'
	Deferred revenue, current portion, consists of the following (in thousands):
		April 30,		October 31,
		2014		2013
		(Unaudited)
	Product	$	40	$	47
	Services		1,000		1,043
		$	1,040	$	1,090

LINE_OF_CREDIT_AND_LONG_TERM_L1

LINE OF CREDIT AND LONG TERM LIABILITIES (Tables)	6 Months Ended
	Apr. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt Instruments [Table Text Block]	'
	The principal balance due to Fortress is as follows (in thousands):
		April 30,
		2014
		(Unaudited)
	Principal balance Fortress Term Loans	$	9,167
	Principal balance other		35
	Unaccreted debt discount		-927
	Net carrying value due Fortress		8,275
	Less current portion		-3,501
	Long term portion	$	4,774

STOCKHOLDERS_EQUITY_Tables

STOCKHOLDERS' EQUITY (Tables)	6 Months Ended
	Apr. 30, 2014
Stockholders Equity Note [Abstract]	'
Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]	'
	As a result of credit, common stock and preferred stock transactions, the Company has the following common stock warrants outstanding at April 30, 2014:
	Warrants Outstanding
	Warrant Transaction	Warrants		Weighted
		Outstanding		Average Exercise
				Price
	2010 Private Placement		949,034	$	3.2
	2013 Private Placement		2,129,774	$	2
	2013 Fortress Credit Agreement		1,454,545	$	2.06
	2014 Private Placement		993,311	$	2.45
	Total Warrants		5,526,664
Schedule of Stockholders Equity [Table Text Block]	'
	A rollforward of activity in stockholders equity is presented in the following table as of April 30, 2014 (in thousands, unaudited):
						Additional				Accumulated		Total
		Preferred Stock		Common Stock		Paid-In		Accumulated		Other Comprehensive		Stockholders'
		Amount		Amount		Capital		Deficit		Loss		Equity (Deficit)
	Balance at October 31, 2013	$	-	$	12	$	208,702	$	-216,578	$	-51	$	-7,915
	Transfer preferred stock from temporary equity		4		-		6,390		-		-		6,394
	Stock based compensation, options and warants		-		1		1,977		-		-		1,978
	Expiration of derivative liability		-		-		3,322		-		-		3,322
	Common stock dividends issued to preferred shareholders		-		-		366		-366		-		-
	Sale of common stock		-		2		4,334		-		-		4,336
	Foreign currency translation adjustment		-		-		-		-		3		3
	Net loss		-		-		-		-5,073		-		-5,073
	Balance at April 30, 2014	$	4	$	15	$	225,091	$	-222,017	$	-48	$	3,045

STOCK_OPTIONS_AND_STOCK_BASED_1

STOCK OPTIONS AND STOCK BASED COMPENSATION (Tables)	6 Months Ended
	Apr. 30, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'
Schedule Of Employees And Non Employees Service Share Based Compensation Allocation Of Recognized Period Costs [Table Text Block]	'
	The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:
			Six months ended April 30,
			2014			2013
			(Unaudited)			(Unaudited)
	Cost of revenue		$	21		$	14
	Sales and marketing			232			144
	Research and development			362			167
	General and administrative			393			232
	Total stock-based compensation		$	1,008		$	557
Variables Used In Black Sholes Calculation [Table Text Block]	'
	The variables used in the Black-Scholes calculation are listed below for the respective periods:
			Six months ended April 30,
			2014				2013
	Expected dividend yield			0	%			0	%
	Expected volatility			73 - 79	%			71 - 74	%
	Risk-free interest rate			1.4 - 1.7	%			0.7 - 0.9	%
	Expected term (years)			5-Apr				6.5
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	The following table summarizes information about stock option activity for the three months ended April 30, 2014 (unaudited):
			Number of			Weighted			Weighted Average		Aggregate
			Shares			Average			Remaining		Intrinsic
						Exercise Price			Contractual Term		Value ($M)
									(years)
	Outstanding at October 31, 2013			3,320,910		$	2.71			6.43	$	-
	Granted			639,088		$	1.81
	Forfeited			-216,357		$	4.88
	Exercised			-242,208		$	1.56
	Outstanding and expected to vest at April 30, 2014			3,501,433		$	2.49			7.23	$	1.1
	Exercisable at April 30, 2014			1,917,918		$	2.91			5.62	$	0.6
Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans To Employees and Non Employees By Exercise Price Range [Table Text Block]	'
	The following table shows information about outstanding stock options at April 30, 2014:
									Options Outstanding						Options Exercisable
											Weighted
											Average		Weighted				Weighted
	Range of								Shares		Remaining		Average				Average
	Exercise Prices								Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
	$	-		-		$	1.03			184,606		7.7	$	0.89		184,606	$	0.89
	$	1.21		-		$	1.21			395,000		9.5	$	1.21		98,750	$	1.21
	$	1.24		-		$	1.54			521,506		9.51	$	1.5		184,006	$	1.43
	$	1.54		-		$	2.04			342,616		6.24	$	1.63		298,275	$	1.62
	$	2.04		-		$	2.1			864,368		9.12	$	2.1		199,137	$	2.1
	$	2.1		-		$	3.52			423,429		6.03	$	2.92		266,704	$	3.16
	$	3.52		-		$	4.75			524,172		3.23	$	4.58		463,327	$	4.58
	$	4.75		-		$	7.2			245,736		3.77	$	5.2		223,113	$	5.23
	$	-		-		$	7.2			3,501,433		7.23	$	2.49		1,917,918	$	2.91

ORGANIZATION_AND_BASIS_OF_PRES2

ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Organization And Basis Of Presentation [Line Items]	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	12,811,794	9,587,096	12,811,794	9,587,096
Preferred Stock Dividends, Paid and Accrued	$93	$864	$248	$864
Warrant [Member]	'	'	'	'
Organization And Basis Of Presentation [Line Items]	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	'	'	5,526,664	3,280,849
Convertible Preferred Stock [Member]	'	'	'	'
Organization And Basis Of Presentation [Line Items]	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	'	'	3,783,697	4,231,154
Employee Stock Option [Member]	'	'	'	'
Organization And Basis Of Presentation [Line Items]	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	'	'	3,501,433	2,075,093

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'
Balance October 31, 2013	$772
Derivative liability converted to equity upon exercise	-215
Change in fair value of derivative liability	2,765
Derivative liability reclassified to equity upon ratchet expiration	-3,322
Balance April 30, 2014	$0

FAIR_VALUE_MEASUREMENTS_Detail1

FAIR VALUE MEASUREMENTS (Details Textual) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Preferred Stock, Value, Outstanding	6.4
Financial and Nonfinancial Liabilities, Fair Value Disclosure, Total	0.8
Series F Convertible Preferred Stock [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Preferred Stock, Dividend Rate, Percentage	5.00%

INVENTORY_Details

INVENTORY (Details) (USD $)	Apr. 30, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'
Raw materials	$199	$204
Finished goods	106	109
Inventory, Net	$305	$313

PROPERTY_AND_EQUIPMENT_Details

PROPERTY AND EQUIPMENT (Details) (USD $)	Apr. 30, 2014	Oct. 31, 2013	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014
In Thousands, unless otherwise specified			Machinery and Equipment [Member]	Machinery and Equipment [Member]	Furniture and Fixtures [Member]	Leasehold Improvements [Member]
			Minimum [Member]	Maximum [Member]
Property, Plant and Equipment [Line Items]	'	'	'	'	'	'
Equipment	$17,659	$18,390	'	'	'	'
Furniture and fixtures	796	789	'	'	'	'
Leasehold improvements	576	576	'	'	'	'
Property, Plant and Equipment, Gross	19,031	19,755	'	'	'	'
Less: Accumulated depreciation	-18,324	-18,724	'	'	'	'
Property Plant And Equipment Net	$707	$1,031	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'1 year	'3 years	'5 years	'5 years

PROPERTY_AND_EQUIPMENT_Details1

PROPERTY AND EQUIPMENT (Details Textual) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013
Property, Plant and Equipment [Line Items]	'	'
Depreciation	$380	$409

ACCRUED_EXPENSES_AND_DEFERRED_2

ACCRUED EXPENSES AND DEFERRED REVENUE (Details) (USD $)	Apr. 30, 2014	Oct. 31, 2013	Oct. 31, 2012
In Thousands, unless otherwise specified
Accrued Expenses And Deferred Revenue [Line Items]	'	'	'
Payroll related	$550	$1,470	'
Professional services	226	359	'
Warranty reserve	48	41	11
Other	107	225	'
Accrued Liabilities Current	$931	$2,095	'

ACCRUED_EXPENSES_AND_DEFERRED_3

ACCRUED EXPENSES AND DEFERRED REVENUE (Details 1) (USD $)	6 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Oct. 31, 2013
Product Warranty Accrual [Line Items]	'	'
Balance at Beginning of Period, Warranty reserve	$41	$11
Charged to Costs and Expenses, Warranty reserve	17	58
Reserve Usage, Warranty reserve	-10	-28
Balance at End of Period, Warranty reserve	$48	$41

ACCRUED_EXPENSES_AND_DEFERRED_4

ACCRUED EXPENSES AND DEFERRED REVENUE (Details 2) (USD $)	Apr. 30, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Deferred Revenue For Product And Services [Line Items]	'	'
Deferred revenue	$1,040	$1,090
Product [Member]	'	'
Deferred Revenue For Product And Services [Line Items]	'	'
Deferred revenue	40	47
Services[Member]	'	'
Deferred Revenue For Product And Services [Line Items]	'	'
Deferred revenue	$1,000	$1,043

ACCRUED_EXPENSES_AND_DEFERRED_5

ACCRUED EXPENSES AND DEFERRED REVENUE (Details Textual) (USD $)	6 Months Ended	12 Months Ended
	Apr. 30, 2014	Oct. 31, 2013
Accrued Expenses And Deferred Revenue [Line Items]	'	'
Accrued Bonuses, Current	'	$202,000
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures	135,000	'
Stock Issued During Period, Shares, Share-Based Compensation, Net Of Forfeitures (in shares)	66,081	147,000
Employee Severance [Member]	'	'
Accrued Expenses And Deferred Revenue [Line Items]	'	'
Severance Costs Payable	'	326,000
Chief Executive Officer [Member] | Employee Severance [Member]	'	'
Accrued Expenses And Deferred Revenue [Line Items]	'	'
Severance Costs Payable	'	$142,000

LINE_OF_CREDIT_AND_LONG_TERM_L2

LINE OF CREDIT AND LONG TERM LIABILITIES (Details) (USD $)	Apr. 30, 2014	Oct. 31, 2013
Line of Credit Facility [Line Items]	'	'
Less current portion	($3,501,000)	($1,605,000)
Long term portion	4,774,000	6,984,000
Fortress [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Principal balance	9,167,000	'
Principal balance other	35,000	'
Unaccreted debt discount	-927,000	'
Net carrying value due Fortress	8,275,000	'
Less current portion	-3,501,000	'
Long term portion	$4,774,000	'

LINE_OF_CREDIT_AND_LONG_TERM_L3

LINE OF CREDIT AND LONG TERM LIABILITIES (Details Textual) (Fortress [Member], USD $)	6 Months Ended
	Apr. 30, 2014	Jul. 24, 2013
Line of Credit Facility [Line Items]	'	'
Debt Instrument, Face Amount	$10,000,000	'
Debt Instrument, Interest Rate, Stated Percentage	10.00%	'
Debt Instrument Drew Down Amount	'	10,000,000
Debt Instrument, Description	'The Company is required to maintain a minimum of $1.5 million of unrestricted cash at each month end and the Company is restricted from making certain cash distributions to equity security holders or from incurring additional indebtedness without prior written consent from Fortress. The Company has also agreed to certain reporting covenants and must supply monthly financial statements to Fortress within 30 days of the end of each month	'
Debt Instrument, Interest Rate, Effective Percentage	13.37%	'
Debt Issuance Cost	1,700,000	'
Warrants To Purchase Common Stock	1,454,545	'
Warrants Exercise Price	$2.06	'
Term Loan A [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Debt Instrument, Face Amount	5,000,000	'
Debt Instrument, Maturity Date	22-Jul-16	'
Debt Instrument, Interest Rate, Stated Percentage	10.00%	'
Debt Instrument, Interest Rate Terms	'bearing no interest for the first 12 months	'
Term Loan B [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Debt Instrument, Face Amount	$5,000,000	'
Debt Instrument, Maturity Date	1-Feb-16	'
Debt Instrument, Interest Rate Terms	'bearing no interest for the first six months	'

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details Textual) (USD $)	6 Months Ended		0 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	2-May-14	Apr. 30, 2014
			Subsequent Event [Member]	Crossroads Headquarters [Member]
			sqft	sqft
Commitments And Contingencies [Line Items]	'	'	'	'
Operating Leases, Rent Expense, Net	$191,000	$205,000	'	'
Area of Land	'	'	16,200	37,800
Lease Commitment Description	'	'	'an extension agreement through February 28, 2015. On May 2, 2014, the lease was amended, extending the lease through March 31, 2020	'
Lease Commitment Value	'	'	$264,000	'

STOCKHOLDERS_EQUITY_Details

STOCKHOLDERS' EQUITY (Details) (USD $)	Apr. 30, 2014
Warrants [Line Items]	'
Warrants Outstanding	5,526,664
2010 Private Placement Warrant [Member]	'
Warrants [Line Items]	'
Warrants Outstanding	949,034
Weighted Average Exercise Price	3.2
2013 Private Placement Warrant [Member]	'
Warrants [Line Items]	'
Warrants Outstanding	2,129,774
Weighted Average Exercise Price	2
2013 Fortress Credit Agreement Warrant [Member]	'
Warrants [Line Items]	'
Warrants Outstanding	1,454,545
Weighted Average Exercise Price	2.06
2014 Private Placement Warrant [Member]	'
Warrants [Line Items]	'
Warrants Outstanding	993,311
Weighted Average Exercise Price	2.45

STOCKHOLDERS_EQUITY_Details_1

STOCKHOLDERS' EQUITY (Details 1) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Stock Issuance And Proceeds [Line Items]	'	'	'	'
Balance at October 31, 2013	'	'	($7,915)	'
Transfer Preferred Stock from Temporary Equity	'	'	6,394	'
Stock based compensation, options and warants	'	'	1,978	'
Expiration of derivative liability	'	'	3,322	'
Common stock dividends issued to preferred shareholders	'	'	0	'
Sale of common stock	'	'	4,336	'
Foreign currency translation adjustment	'	'	3	'
Net loss	-1,741	-3,950	-5,073	-7,095
Balance at April 30, 2014	3,045	'	3,045	'
Preferred Stock [Member]	'	'	'	'
Stock Issuance And Proceeds [Line Items]	'	'	'	'
Balance at October 31, 2013	'	'	0	'
Transfer Preferred Stock from Temporary Equity	'	'	4	'
Stock based compensation, options and warants	'	'	0	'
Expiration of derivative liability	'	'	0	'
Common stock dividends issued to preferred shareholders	'	'	0	'
Sale of common stock	'	'	0	'
Foreign currency translation adjustment	'	'	0	'
Net loss	'	'	0	'
Balance at April 30, 2014	4	'	4	'
Common Stock [Member]	'	'	'	'
Stock Issuance And Proceeds [Line Items]	'	'	'	'
Balance at October 31, 2013	'	'	12	'
Transfer Preferred Stock from Temporary Equity	'	'	0	'
Stock based compensation, options and warants	'	'	1	'
Expiration of derivative liability	'	'	0	'
Common stock dividends issued to preferred shareholders	'	'	0	'
Sale of common stock	'	'	2	'
Foreign currency translation adjustment	'	'	0	'
Net loss	'	'	0	'
Balance at April 30, 2014	15	'	15	'
Additional Paid-In Capital [Member]	'	'	'	'
Stock Issuance And Proceeds [Line Items]	'	'	'	'
Balance at October 31, 2013	'	'	208,702	'
Transfer Preferred Stock from Temporary Equity	'	'	6,390	'
Stock based compensation, options and warants	'	'	1,977	'
Expiration of derivative liability	'	'	3,322	'
Common stock dividends issued to preferred shareholders	'	'	366	'
Sale of common stock	'	'	4,334	'
Foreign currency translation adjustment	'	'	0	'
Net loss	'	'	0	'
Balance at April 30, 2014	225,091	'	225,091	'
Accumulated Deficit [Member]	'	'	'	'
Stock Issuance And Proceeds [Line Items]	'	'	'	'
Balance at October 31, 2013	'	'	-216,578	'
Transfer Preferred Stock from Temporary Equity	'	'	0	'
Stock based compensation, options and warants	'	'	0	'
Expiration of derivative liability	'	'	0	'
Common stock dividends issued to preferred shareholders	'	'	-366	'
Sale of common stock	'	'	0	'
Foreign currency translation adjustment	'	'	0	'
Net loss	'	'	-5,073	'
Balance at April 30, 2014	-222,017	'	-222,017	'
Accumulated Other Comprehensive Loss [Member]	'	'	'	'
Stock Issuance And Proceeds [Line Items]	'	'	'	'
Balance at October 31, 2013	'	'	-51	'
Transfer Preferred Stock from Temporary Equity	'	'	0	'
Stock based compensation, options and warants	'	'	0	'
Expiration of derivative liability	'	'	0	'
Common stock dividends issued to preferred shareholders	'	'	0	'
Sale of common stock	'	'	0	'
Foreign currency translation adjustment	'	'	3	'
Net loss	'	'	0	'
Balance at April 30, 2014	($48)	'	($48)	'

STOCKHOLDERS_EQUITY_Details_Te

STOCKHOLDERS' EQUITY (Details Textual) (USD $)

3 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

12 Months Ended

Jan. 31, 2014

Apr. 30, 2014

Oct. 31, 2013

Mar. 22, 2013

Oct. 31, 2013

Apr. 30, 2014

Oct. 31, 2010

Oct. 31, 2013

Apr. 30, 2014

Apr. 30, 2014

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Jul. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

2013 Private Placement Warrant [Member]

2013 Private Placement Warrant [Member]

2013 Private Placement Warrant [Member]

2010 Private Placement Warrant [Member]

2013 Fortress Credit Agreement Warrant [Member]

2014 Private Placement Warrant [Member]

Series F Convertible Preferred Stock [Member]

Series F Convertible Preferred Stock [Member]

Certificate Of Designation [Member]

Certificate Of Designation [Member]

Certificate Of Designation [Member]

Iron Mountain Incorporated [Member]

Investors [Member]

Investors [Member]

Investor One [Member]

Investor Two [Member]

Series F1 Convertible Preferred Stock [Member]

Series F2 Convertible Preferred Stock [Member]

Convertible Notes Payable [Member]

Series F Convertible Preferred Stock [Member]

Series F Convertible Preferred Stock [Member]

Convertible Notes Payable [Member]

Convertible Notes Payable [Member]

Stock Holders Equity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period Shares New Issues One

'

'

'

'

'

'

3,125,000

'

1,986,622

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, New Issues, Par Value Per Share

'

'

'

'

'

'

$3.20

'

$2.26

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period Value New Issues One

'

'

'

'

'

'

$10,000,000

'

$4,500,000

'

'

'

'

'

'

'

'

'

'

Number Of Common Stock, Shares Granted By Issue Of Warrants Under Private Placement

'

'

'

'

'

'

1,074,212

'

993,311

'

'

'

'

'

'

'

'

'

'

Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants

'

'

'

'

'

'

$3.20

'

$2.45

'

'

'

'

'

'

'

'

'

'

Payments of Stock Issuance Costs

'

'

'

'

'

'

800,000

'

200,000

'

'

'

'

'

'

'

'

'

'

Fair Value Of Warrants

'

'

'

2,284,000

772,000

'

1,300,000

1,374,000

1,100,000

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions, Expected Dividend Rate

'

'

'

0.00%

0.00%

'

0.00%

'

0.00%

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions, Expected Volatility Rate

'

'

'

63.00%

65.00%

'

63.00%

'

74.00%

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions, Risk Free Interest Rate

'

'

'

0.82%

1.10%

'

1.47%

'

1.64%

'

'

'

'

'

'

'

'

'

'

Fair Value Assumptions, Expected Term

'

'

'

'5 years

'4 years 4 months 24 days

'

'5 years

'

'2 years 6 months

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Date from which Warrants or Rights Exercisable

'

'

'

'

'

'

22-Oct-15

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued (in shares)

'

15,045,049

11,949,937

'

'

'

'

'

'

'

'

'

'

'

582,524

'

'

'

'

Common Stock, Par Or Stated Value Per Share (in dollars per share)

'

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

$5.15

'

'

'

'

Common Stock, Value, Issued (in shares)

'

15,000

12,000

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

'

Securities Purchase Agreement, Number Of Units Issuable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,231,154

'

'

'

Securities Purchase Agreement, Price Per Unit Of Units Issuable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.0625

'

'

'

Securities Purchase Agreement, Value Of Units Issuable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,600,000

'

'

'

Securities Purchase Agreement, Proceeds From Issuance Of Units

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,900,000

'

'

'

Preferred Stock, Shares Authorized

'

25,000,000

0

'

'

'

'

'

'

'

'

4,500,000

3,750,000

750,000

'

'

'

'

'

Preferred Stock, Conversion Basis

'

'

'

'

'

'

'

'

'

'

'

'The right of holders of convertible preferred stock to convert the convertible preferred stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2.

'

'

'

'

'

'

'

Preferred Stock, Voting Rights

'

'

'

'

'

'

'

'

'

'

'

'

'Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the Original Issue Date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company.

'The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1.

'

'

'

'

'

Units, Par Or Stated Value Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

Securities Purchase Agreement, Number Of Warrants Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,282,754

'

'

'

Securities Purchase Agreement, Exercise Price Of Warrants Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2

'

'

'

Securities Purchase Agreement, Units Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

700,000

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

550,000

'

'

Debt Instrument, Convertible, Terms of Conversion Feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Pursuant to the terms of the notes, both note holders had the right to convert the outstanding amounts under their notes into Series F convertible preferred stock shares at a discount of 15% to the issue price of the Series F convertible preferred stock.

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

188,235

156,863

Convertible preferred shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

330,000

275,000

Warrants Convertible Beneficial Conversion Feature

'

'

'

1,090,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends, Stock, Total

'

'

'

'

106,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Dividends, Shares

150,703

'

'

'

57,097

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Of Warrants, Per Share

'

'

'

'

'

'

'

$1.06

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Beneficial Conversion Feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

107,000

'

'

Preferred Stock, Value, Outstanding

'

'

6,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

'

'

'

'

'

'

'

5.00%

'

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Increased Percentage

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Stock Dividend

366,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Converted

'

'

'

'

'

'

'

'

'

447,457

'

'

'

'

'

'

'

'

'

Fair Value of Warrant Liability

'

'

0

'

'

1,543,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Liability, Noncurrent

'

$0

$772,000

'

'

$800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

STOCK_OPTIONS_AND_STOCK_BASED_2

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share Based Compensation To Employees and Non Employees	$1,008	$557
Cost of revenue [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share Based Compensation To Employees and Non Employees	21	14
Selling and marketing [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share Based Compensation To Employees and Non Employees	232	144
Research and development [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share Based Compensation To Employees and Non Employees	362	167
General and administrative [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share Based Compensation To Employees and Non Employees	$393	$232

STOCK_OPTIONS_AND_STOCK_BASED_3

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 1)	6 Months Ended
	Apr. 30, 2014	Apr. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected dividend yield	0.00%	0.00%
Expected volatility, Minimum	73.00%	71.00%
Expected volatility, Maximum	79.00%	74.00%
Risk-free interest rate, Minimum	1.40%	0.70%
Risk-free interest rate, Maximum	1.70%	0.90%
Expected term (years)	'	'6 years 6 months
Expected term (years), Minimum	'4 years	'
Expected term (years), Maximum	'5 years	'

STOCK_OPTIONS_AND_STOCK_BASED_4

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 2) (USD $)	6 Months Ended
In Millions, except Share data, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Shares, Outstanding at October 31, 2013	3,320,910	'
Number of Shares, Granted	639,088	'
Number of Shares, Forfeited	-216,357	'
Number of Shares, Exercised	-242,208	'
Number of Shares, Outstanding and expected to vest at April 30, 2014	3,501,433	'
Number of Shares, Exercisable at April 30, 2014	1,917,918	'
Weighted Average Exercise Price, Outstanding at October 31, 2013 (in dollars per share)	$2.71	'
Weighted Average Exercise Price, Granted (in dollars per share)	$1.81	'
Weighted Average Exercise Price, Forfeited (in dollars per share)	$4.88	'
Weighted Average Exercise Price, Exercised (in dollars per share)	$1.56	'
Weighted Average Exercise Price, Outstanding and expected to vest at April 30, 2014 (in dollars per share)	$2.49	'
Weighted Average Exercise Price, Exercisable at April 30, 2014 (in dollars per share)	$2.91	'
Stock Options To Employees and Non Employees Outstanding and expected to vest Weighted Average Remaining Contractual Term (in years)	'7 years 2 months 23 days	'6 years 5 months 5 days
Weighted Average Remaining Contractual Term, Exercisable (in years)	'5 years 7 months 13 days	'
Average Intrinsic Value, Outstanding at October 31, 2013	$0	'
Average Intrinsic Value, Outstanding and expected to vest at April 30, 2014	1.1	'
Average Intrinsic Value, Exercisable at April 30, 2014	$0.60	'

STOCK_OPTIONS_AND_STOCK_BASED_5

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 3) (USD $)	6 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Oct. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$0	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$7.20	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	3,501,433	'	3,320,910
Weighted Average Remaining Contractual Term, Outstanding (in years)	'7 years 2 months 23 days	'6 years 5 months 5 days	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$2.49	'	$2.71
Share Based Payment Award Options Exercisable Number (in shares)	1,917,918	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$2.91	'	'
Range Of Exercise Prices One [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$0	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$1.03	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	184,606	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'7 years 8 months 12 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$0.89	'	'
Share Based Payment Award Options Exercisable Number (in shares)	184,606	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$0.89	'	'
Range Of Exercise Prices Two [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$1.21	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$1.21	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	395,000	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'9 years 6 months	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$1.21	'	'
Share Based Payment Award Options Exercisable Number (in shares)	98,750	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$1.21	'	'
Range Of Exercise Prices Three [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$1.24	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$1.54	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	521,506	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'9 years 6 months 4 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$1.50	'	'
Share Based Payment Award Options Exercisable Number (in shares)	184,006	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$1.43	'	'
Range Of Exercise Prices Four [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$1.54	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$2.04	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	342,616	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'6 years 2 months 26 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$1.63	'	'
Share Based Payment Award Options Exercisable Number (in shares)	298,275	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$1.62	'	'
Range Of Exercise Prices Five [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$2.04	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$2.10	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	864,368	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'9 years 1 month 13 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$2.10	'	'
Share Based Payment Award Options Exercisable Number (in shares)	199,137	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$2.10	'	'
Range Of Exercise Prices Six [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$2.10	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$3.52	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	423,429	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'6 years 11 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$2.92	'	'
Share Based Payment Award Options Exercisable Number (in shares)	266,704	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$3.16	'	'
Range Of Exercise Prices Seven [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$3.52	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$4.75	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	524,172	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'3 years 2 months 23 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$4.58	'	'
Share Based Payment Award Options Exercisable Number (in shares)	463,327	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$4.58	'	'
Range Of Exercise Prices Eight [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit	$4.75	'	'
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit	$7.20	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	245,736	'	'
Weighted Average Remaining Contractual Term, Outstanding (in years)	'3 years 9 months 7 days	'	'
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$5.20	'	'
Share Based Payment Award Options Exercisable Number (in shares)	223,113	'	'
Weighted Average Exercise Price, Exercisable (in dollars per share)	$5.23	'	'

STOCK_OPTIONS_AND_STOCK_BASED_6

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details Textual) (USD $)	6 Months Ended		12 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Oct. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	3,501,433	'	3,320,910
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$1.16	$1.65	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	$217,000	$15,200	'
Proceeds from Stock Options Exercised	377,000	27,000	'
Unrecognized Compensation Cost Related To Non Vested Stock Option Awards To Employees and Nonemployees	900,000	'	'
Expected Weighted Average Period Of Recognition Of Compensation Cost Related To Stock Options To Employees and Non Employees	'10 months 24 days	'	'
Stock Options Vested By Shares To Employees and Non Employees During Period	534,969	206,595	'
Stock Options Vested To Value Of Employees and Non Employees During Period	684,000	424,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	10,000	60,000	'
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value	$14,000	$95,000	'
Estimated Percentage On Management Bonus, Share Based Compensation	'	'	67.00%
Stock Issued During Period, Shares, Share-Based Compensation, Net Of Forfeitures	66,081	'	147,000
Stock Options Granted To Employees and Non Employees During Period	639,088	'	'
Stock Option Plan 1999 [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	663,442	'	'
Stock Options To Employees and Non Employees Vested	1,917,918	'	'
Stock Option Plan 2010 [Member]	'	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Stock Options To Employees and Non Employees Outstanding Number (in shares)	2,837,991	'	'
Stock Options Authorized To Be Issued To Employees and Non Employees	3,500,000	'	'
Criteria For Increase In Number Of Shares Reserved For Options	'four percent (4%) of the total outstanding shares on the last day of the prior calendar year, subject to a maximum annual increase of 250,000	'	'
Stock Options To Employees and Non Employees Options Grants	3,670,622	'	'
Stock Options To Employees and Non Employees Available For Future Grants	143,634	'	'
Number Of Options To Employees and Non Employed Previously Exercised Reduced	221,780	'	'
Common Stock Shares Granted	66,081	146,555	'
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms	'The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. During 2014, the majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter	'	'
Stock Options Granted To Employees and Non Employees During Period	296,595	'	'

EMPLOYEE_BENEFITS_Details_Text

EMPLOYEE BENEFITS (Details Textual) (USD $)	6 Months Ended
	Apr. 30, 2014	Apr. 30, 2013
Employee Benefits [Line Items]	'	'
Defined Contribution Plan, Employer Discretionary Contribution Amount	$91,000	$149,000

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details Textual) (USD $)	6 Months Ended
	Apr. 30, 2014
2014 Private Placement [Member]	'
Related Party Transaction [Line Items]	'
Warrants to Purchase of Common Stock	644,176
Stock Issued During Period, Shares, Acquisitions	1,288,352
Class of Warrant or Right, Exercise Price of Warrants or Rights	$2.45
Adjustments to Additional Paid in Capital, Warrant Issued	$2,900,000
Iron Mountain Incorporated ("IRM") [Member]	'
Related Party Transaction [Line Items]	'
Related Party Transaction, Proceeds from Terminated Contract	1,600,000
Revenue from Related Parties	550,000
Related party transaction, Gain Loss on Contract Termination	$1,050,000

SUBSEQUENT_EVENT_Details_Textu

SUBSEQUENT EVENT (Details Textual) (Subsequent Event [Member])	0 Months Ended
	23-May-14
Subsequent Event [Member]	'
Tax Benefit Preservation Plan, Description	'The Tax Benefit Preservation Plan is designed to deter acquisitions of the Company’s common stock that would result in a stockholder owning 4.99% or more of the Company’s common stock (as calculated under Section 382 of the Internal Revenue Code), or any existing holder of 4.99% or more of the Company’s common stock acquiring additional shares, by substantially diluting the ownership interest of any such stockholder unless the stockholder obtains an exemption from the Company’s board of directors.